What We're Reading: Page 187
Industry reads hand-picked by our editors
Sep 11, 2020
Sep 10, 2020
Sep 09, 2020
-
Reuters
How drugmakers can keep their pledge and still deliver an October vaccine surprise
-
The Wall Street Journal
Recursion Raises $239 Million Series D Round, Strikes Deal With Bayer
-
OneZero
The Next Gene-Edited Babies Could Be Free of Sickle Cell or Muscular Dystrophy
-
Evaluate Vantage
Big pharma spinouts grow up
Sep 08, 2020
-
MarketWatch
AstraZeneca vaccine ‘most likely’ to roll out in the U.K. early next year
-
Bloomberg
Sanofi Plans Ingredients Unit IPO Within Months, Bogillot Says
-
Endpoints News
Grifols makes a $146M bet on a Stanford play in a controversial anti-aging field
-
Pittsburgh Business Times
Mylan to acquire European drug portfolio
Sep 04, 2020
Sep 03, 2020
Sep 02, 2020
-
The Wall Street Journal
‘Russian Roulette’: Inside Putin’s Race to Develop a Covid-19 Vaccine Before the West
-
Bloomberg
Trump’s Claim Drug Companies Are Negotiating Disputed by Lobby
-
Los Angeles Times
California may be first state to develop its own generic drugs
-
POLITICO
FDA shake-up continues as another comms official removed from top role
Previous
